Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel approach to cardiovascular disorders described by SB

Feb. 28, 2000

Phase III trial evaluating beraprost as treatment for moderate pulmonary hypertension

Feb. 28, 2000

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Feb. 25, 2000

Paladin licenses Uniprost to United Therapeutics in Canada

Feb. 23, 2000

Gene therapy improves age-related cardiac disorder in rats

Feb. 23, 2000

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Feb. 23, 2000

JTV-519 may provide cardioprotection by mimicking preconditioning

Feb. 22, 2000

Effective new antianginal agents under study at Lafon

Feb. 22, 2000

NicOx initiates French phase I trial of new oral formulation of NCX-4016

Feb. 22, 2000

NCBE inhibitors in development at Aventis

Feb. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...